Intellectual Property

Family 1 Priority Date Sept 2010

'Serum Preparation'

Covers all prothrombin activators derived from snake venom including naturally- occurring and recombinant versions in blood collection tubes for the production of serum for biochemical analysis.

July 2017: Patent granted in EU, Japan and Australia. Other jurisdictions progressing.

Family 2 Priority Date Oct 2014

'Improved Clotting Composition'

Covers formulations to enhance the temperature and irradiation stability of snake venom-derived prothrombin activators in blood collection tubes.

National Phase commenced.